Inhibition of neuronal nitric oxide synthase in the rat hippocampus induces antidepressant-like effects

Psychopharmacology
Samia R L Joca, Francisco S Guimarães

Abstract

Systemic inhibition of neuronal nitric oxide synthase (nNOS) induces antidepressant-like effects in rodents. The mechanisms and brain regions mediating this effect are still unknown. The hippocampus is a brain region proposed to mediate adaptation to stress and antidepressant behavioral effects. Therefore, it could be involved in the antidepressant effects of NOS inhibitors. To test the hypothesis that nNOS inhibition in the dorsal hippocampus will induce antidepressant-like effects in the forced swimming test (FST) in rats. Rats implanted with cannulas aimed at the dorsal hippocampus were submitted to 15 min of forced swimming (pretest). Immediately before or after pretest they received bilateral microinjections of the nNOS inhibitor 7-nitroindazole (7-NI; 50, 100, or 200 nmol/0.5 microl) or vehicle, alone or combined with L-arginine. Additional groups received SIN-1 (125 or 250 nmol/0.5 microl), a NO donor, either before or after the pretest. Twenty-four hours later, immobility time was registered for 5 min in the FST. 7-NI (100 nmol) significantly decreased immobility time when administered either before or after pretest. Pretreatment with L-arginine (100 nmol/0.5 microl) prevented these effects but produced no significant e...Continue Reading

References

Jul 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·V L DawsonS H Snyder
Aug 1, 1990·Physiology & Behavior·E L Abel, P J Bilitzke
Mar 30, 1990·Biochemical and Biophysical Research Communications·M HeckerJ R Vane
May 1, 1987·Biological Psychiatry·G J NaylorP Connelly
Apr 30, 1996·Proceedings of the National Academy of Sciences of the United States of America·Y I ShelineM W Vannier
Jan 11, 1996·European Journal of Pharmacology·D Jefferys, J Funder
May 1, 1996·Pharmacology, Biochemistry, and Behavior·F G GraeffJ F Deakin
Jun 1, 1997·Current Opinion in Neurobiology·J E Brenman, D S Bredt
Jul 1, 1997·Archives of General Psychiatry·R S DumanE J Nestler
Jan 27, 1998·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·L Eroğlu, B Cağlayan
Apr 18, 1998·Proceedings of the National Academy of Sciences of the United States of America·E GouldE Fuchs
Jun 4, 1998·Pharmacology, Biochemistry, and Behavior·D A CzechK T Le Sueur
May 26, 1999·Pharmacology, Biochemistry, and Behavior·J O CampbellL P Spear
Dec 10, 1999·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·R W de-Oliveira, F S Guimarães
Apr 13, 2000·Brain Research. Brain Research Reviews·A Contestabile
May 24, 2000·British Journal of Pharmacology·G WegenerR Rosenberg
Nov 4, 2000·The American Journal of Psychiatry·S H Snyder, C D Ferris
Mar 14, 2001·Journal of Affective Disorders·E SuzukiM Asai
Mar 16, 2001·Progress in Neurobiology·H Prast, A Philippu
Feb 28, 2002·Proceedings of the National Academy of Sciences of the United States of America·Marco CanossaSergio Ferri
Mar 6, 2002·British Journal of Pharmacology·Juan V Esplugues
Apr 5, 2002·Neuron·Eric J NestlerLisa M Monteggia
Aug 23, 2002·Behavioural Brain Research·Ida Louise HeibergRaben Rosenberg
Mar 26, 2003·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Pierre Blier
Jul 2, 2003·Brain Research·Sâmia Regiane Lourenço JocaFrancisco Silveira Guimarães
Jul 3, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Jessica E Malberg, Ronald S Duman
Aug 6, 2003·The American Journal of Psychiatry·Yvette I ShelineHelena C Kraemer

❮ Previous
Next ❯

Citations

Mar 13, 2010·Psychopharmacology·Jonathan B KelleyYossef Itzhak
Sep 18, 2008·Behavioural Pharmacology·Frederico R FerreiraFrancisco S Guimarães
Apr 9, 2014·Behavioural Pharmacology·Vinicius A Hiroaki-SatoSâmia R L Joca
Sep 13, 2011·Neurochemical Research·Eduardo von Poser ToigoCarla Dalmaz
Nov 30, 2011·International Journal of Psychiatry in Clinical Practice·Hande YapislarÜnal Ozüm
Feb 24, 2016·Neuroscience and Biobehavioral Reviews·Anastasiya SlyepchenkoAndré F Carvalho
Jan 13, 2016·Naunyn-Schmiedeberg's Archives of Pharmacology·Sattar OstadhadiAhmadReza Dehpour
Apr 21, 2012·Neuroscience·S A SavelyevT Porkka-Heiskanen
Feb 22, 2011·Nitric Oxide : Biology and Chemistry·Ashish Dhir, S K Kulkarni
Jul 27, 2010·Progress in Neuro-psychopharmacology & Biological Psychiatry·Hideki HorikawaShigenobu Kanba
Jul 6, 2010·Behavioural Brain Research·America Augusto ScopinhoSâmia Regiane Lourenço Joca
Jan 28, 2010·Life Sciences·Cristiani F BortolattoCristina W Nogueira
Dec 1, 2009·Pharmacology, Biochemistry, and Behavior·Valentina GigliucciAndrew Harkin
Sep 16, 2008·European Journal of Pharmacology·Patrícia de Souza BrocardoAna Lúcia S Rodrigues
Jul 1, 2008·European Journal of Pharmacology·Shrinivas K Kulkarni, Ashish Dhir
Mar 24, 2007·Progress in Neuro-psychopharmacology & Biological Psychiatry·Ashish Dhir, S K Kulkarni
Mar 5, 2011·International Journal of Stroke : Official Journal of the International Stroke Society·Michaela C PascoeDavid P Crewther

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.